Thus, while ROS-driven oncogenic pathways, such as PI3K/Akt and MAPK, are widely implicated in tumor initiation and progression, their context-dependent responses, particularly in relation to tumor suppressors like PTEN and p53, highlight a critical need to dissect tumor-type-specific redox adaptations. The gene discussed is AKT1; the disease is neoplasm.